Liaoning Heshi Ophthalmic Hospital Group Co., Ltd
Initial public offering and listing on GEM
Announcement of preliminary placement results of offline issuance
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375)
hot tip
The application of Liaoning Heshi ophthalmology hospital group Co., Ltd. (hereinafter referred to as “Heshi ophthalmology” or “the issuer”) for the initial public offering of RMB common shares (A shares) (hereinafter referred to as “this offering”) and listing on the gem has been examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”), It has been approved to register by China Securities Regulatory Commission (hereinafter referred to as “CSRC”) (zjxk [2022] No. 126).
The issuer and the sponsor (lead underwriter) Central China Securities Co.Ltd(601375) (hereinafter referred to as ” Central China Securities Co.Ltd(601375) ” or “sponsor (lead underwriter)”) negotiated and determined that the number of shares issued this time was 30.5 million. The offering price is 42.50 yuan / share, which does not exceed the median and weighted average of offline investors’ quotations after excluding the highest quotation, as well as the Securities Investment Fund (hereinafter referred to as “public fund”) and the National Social Security Fund (hereinafter referred to as “social security fund”) established through public offering after excluding the highest quotation The lower of the median and weighted average of the quoted price of the basic endowment insurance fund (hereinafter referred to as “pension”), the enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund (hereinafter referred to as “enterprise annuity fund”) and the insurance fund (hereinafter referred to as “insurance fund”) in accordance with the measures for the administration of the use of insurance funds.
According to the issuing price, the relevant subsidiaries of the sponsor will not participate in the strategic placement. Finally, this issuance will not be targeted to strategic investors. The difference between the initial strategic placement and the final strategic placement is 1525000 shares, which are transferred back to offline issuance.
This issuance is finally carried out by a combination of offline inquiry and placement to qualified investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-share shares in Shenzhen market and the market value of non restricted Depositary Receipts (hereinafter referred to as “online issuance”).
Before the launch of the online and offline call back mechanism and after the strategic placement call back, the initial number of offline shares was 218075 million, accounting for 71.50% of the number of shares issued this time; The initial number of shares issued online was 8.6925 million, accounting for 28.50% of the number issued this time.
According to the callback mechanism announced in the announcement of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. on initial public offering and listing on the gem (hereinafter referred to as the “issuance announcement”), since the initial effective subscription multiple on the Internet is 968693955 times, higher than 100 times, the issuer and the sponsor (lead underwriter) decided to start the callback mechanism, 20% (6.1 million shares) of the number of shares issued this time will be transferred back from offline to online. After the call back, the final number of offline shares issued was 157075 million, accounting for 51.50% of the total issued this time; The final number of shares issued online was 14792500, accounting for 48.50% of the total issued this time. After the callback mechanism was launched, the final winning rate of online issuance was 00175675132%, and the subscription multiple was 569232530 times.
Please pay attention to the payment link of this offering and fulfill the payment obligation in time on March 14, 2022 (T + 2). The details are as follows:
1. Offline investors shall, according to the announcement on the initial public offering of shares by Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. and the preliminary placement results of offline issuance listed on the gem, pay the subscription funds for new shares in full and on time according to the final issue price and the number of shares allocated before 16:00 on March 14 (T + 2) 2022.
The subscription funds shall be paid in full within the specified time. If the subscription funds are not paid in full within the specified time or as required, all the new shares allocated to the placing object shall be invalid. If the above-mentioned circumstances occur when multiple new shares are issued on the same day, all the placing objects are invalid. If different placing objects share bank accounts, if the subscription funds are insufficient, all the new shares allocated to the placing objects sharing bank accounts will be invalid. Offline investors are allocated multiple new shares on the same day. Please pay for each new share separately and fill in the remarks according to the specifications. If the placing object has insufficient funds for a single new share, all the new shares allocated to the placing object on that day will be invalid, and the resulting consequences shall be borne by the investors themselves.
The shares that offline investors give up to subscribe for are underwritten by the sponsor (lead underwriter).
2. Among the stocks issued this time, the stocks issued online have no circulation restrictions and limited sales period arrangements, and can be circulated from the date when the stocks issued this time are listed on the Shenzhen Stock Exchange.
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
3. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of shares issued this time, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investor who provides effective quotation fails to participate in the subscription or the offline investor who obtains the preliminary placement fails to pay the subscription amount in time and in full, it will be deemed as a breach of contract and shall bear the liability for breach of contract. The recommendation institution (lead underwriter) shall report the breach of contract to the China Securities Association for the record. The number of shares illegally sold on the Beijing stock exchange (hereinafter referred to as “Beijing stock exchange”) and the Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”). During the period of being included in the restricted list, the placing object shall not participate in the offline inquiry and placement of relevant projects in all sectors of the stock market of Beijing stock exchange, Shanghai Stock Exchange and Shenzhen Stock Exchange.
5. Once this announcement is published, it shall be deemed to have served the notice of allocated payment to the offline investors who have participated in the offline subscription. 1、 Final result of strategic placement
The issue price does not exceed the lower of the median and weighted average of offline investors’ quotations after excluding the highest quotation and the median and weighted average of public funds, social security funds, pensions, enterprise annuity funds and insurance funds after excluding the highest quotation. Therefore, the relevant subsidiaries of the sponsor need not participate in the follow-up investment.
This offering does not arrange strategic placement to other investors.
Finally, this issuance will not be targeted to strategic investors. 2、 Offline issuance and subscription and preliminary placement results
(I) offline issuance and subscription
According to the measures for the administration of securities issuance and underwriting (CSRC order [No. 144]), the special provisions on the issuance and underwriting of initial public offerings on the gem (CSRC announcement [2021] No. 21), the implementation rules for the issuance and underwriting of initial public offerings on the gem of Shenzhen Stock exchange (revised in 2021) (SZS [2021] No. 919) Detailed rules for the implementation of offline issuance of initial public offerings in Shenzhen market (revised in 2020) (SZS [2020] No. 483), rules for the administration of offline investors of initial public offerings under the registration system (czxf [2021] No. 212), code for underwriting of initial public offerings under the registration system (czxf [2021] No. 213) In accordance with the detailed rules for the administration of offline investors in initial public offerings (zxsf [2018] No. 142) and other relevant regulations, the sponsor (lead underwriter) verified and confirmed the qualification of investors participating in offline subscription. According to the effective subscription results finally received by the offline issuance electronic platform of Shenzhen Stock Exchange, the sponsor (lead underwriter) makes the following statistics:
The offline subscription of this offering has been completed on March 10, 2022 (t day). After verification, it is confirmed that the 7504 effective quotation placement objects managed by 334 offline investors disclosed in the issuance announcement have all made offline subscription in accordance with the requirements of the issuance announcement, and the effective subscription quantity is 5654820 million shares.
(II) preliminary offline placement results
According to the offline placement principles and calculation methods published in the announcement on initial public offering and listing on the gem of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. (hereinafter referred to as the “announcement on preliminary inquiry and recommendation”), the issuer and the sponsor (lead underwriter) made a preliminary placement of offline issued shares, The effective subscription and preliminary placement of various offline investors are shown in the table below:
The proportion of the number of shares effectively subscribed by the investor category in the proportion of the initial placement shares effectively applied for offline in the proportion of the final placement shares issued offline (10000 shares) in the total number of shares purchased (10000 shares) in the number of lines
Class a investors 317139056.08% 12235119 77.89% 003857013%
Class B investors 231200.41% 4.3883 0.28% 001897492%
Class C investors 246031043.51% 342849821.83% 001394147%
Total 5654820100.00% 15707500 100.00%-
Note: if the total number is inconsistent with the mantissa of the sum of the sub item values, it is caused by rounding.
Among them, the remaining 1524 shares were placed to the placement object “Ruiyuan steady allocation two-year holding hybrid securities investment fund” managed by “Ruiyuan Fund Management Co., Ltd.” in accordance with the offline placement principle in the preliminary inquiry and promotion announcement. See “attached table: preliminary placement list of offline investors” for the allocation of each placement object. 3、 Contact information of sponsor (lead underwriter)
If the above offline investors have any questions about the offline preliminary placement results announced in this announcement, please contact the sponsor (lead underwriter) of this offering. The specific contact information is as follows:
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375)
Tel: 01057058347, 01057058348
Contact: capital market headquarters
Issuer: sponsor (lead underwriter) of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd.: Central China Securities Co.Ltd(601375) March 14, 2022 Initial public offering results of Liaoning Ophthalmology Group Co., Ltd. (sealed on the next page)
Issuer: Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. (this page has no text and is the sealed page of the announcement on the initial public offering of shares and initial placement results of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. under the GEM Listing network)
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375) preliminary placement list of offline investors on mm / DD / yyyy
Serial number name of investor name of placing object number of shares subscribed type of shares allocated / 10000 shares / share
1 Bohai Securities Co., Ltd. Bohai Securities Co., Ltd. 10101408 C
2 China Greatwall Securities Co.Ltd(002939) China Greatwall Securities Co.Ltd(002939) self operated account 10101408 C
3 China Greatwall Securities Co.Ltd(002939) Great Wall Fuxiang No. 3 single asset management plan 140195 C
4 Tianfeng Securities Co.Ltd(601162) Tianfeng Securities Co.Ltd(601162) 1010 1,408 C
5 First Capital Securities Co.Ltd(002797) chuangying Xinxiang No. 26 directional asset management plan 150209 C
6 First Capital Securities Co.Ltd(002797) chuangying Xinxiang No. 27 directional capital
